Practice Point®: Hematology

Practice Point Communications

Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more. With in-depth discussions from leading hematologists, and insights from real-world cases, this podcast series provides healthcare professionals with the knowledge needed to navigate the world of blood disorders. Stay informed about cutting-edge research and hear inspiring stories of innovation in hematologic care.

Play

Open in

20 episodes
Avg 22 min
English

Episodes 20

Newest Oldest Longest

All20 Unplayed20 In progress0 Played0

#51
July 2 · 7 min
Episode 51 - Podcast: What I'd Do Differently Tomorrow - Part 5 of RRMM Podcasts: Practical Insights for the First Relapse
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
#50
July 2 · 7 min
Episode 50 - Podcast: From Knowing to Doing: Overcoming Real-World Barriers - Part 4 of RRMM Podcasts: Practical Insights for the First Relapse
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
#49
July 2 · 14 min
Episode 49 - Podcast: Bispecific Antibodies Across Targets: Practical Integration in RRMM - Part 3 of RRMM Podcasts: Practical Insights for the First Relapse
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
#48
July 2 · 15 min
Episode 48 - Podcast: Making Sense of Immunotherapy Targets - Part 2 of RRMM Podcasts: Practical Insights for the First Relapse
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
#47
July 2 · 12 min
Episode 47 - Podcast: First Relapse Sets the Course - Part 1 of RRMM Podcasts: Practical Insights for the First Relapse
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice. Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM. Launch Date/Release: July 2, 2026 Expiration Date: August 31, 2027 FACULTY Ajai Chari, MD Professor of Clinical Medicine University of California, San Francisco Sagar Lonial, MD, FACP, FASCO Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Caner Institute | Emory University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
#46
Dec 17, 2025 · 29 min
Episode 46 - What's New Doc? End-of-the-Year Updates on CAR T-cell Therapy in Multiple Myeloma Podcast
CAR T-cell therapies have transformed the management of several previously incurable, treatment-refractory hematologic malignancies, including Multiple Myeloma (MM). With two CAR T-cell products now approved, and additional under investigation, the therapeutic landscape continues to evolve rapidly. In this educational podcast, Dr. Joseph Mikhael highlights key advances in CAR T-cell therapy for MM. He reviews the most impactful data published or presented in 2025 and offers expert insight into how these emerging findings may shape current and future treatment strategies. Launch/Release Date: December 17, 2025 Activity Expiration Date: November 30, 2026 FACULTY Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO Professor, Clinical Genomics and Therapeutics Translational Genomics Research Institute (TGen), City of Hope Cancer Center Chief Medical Officer International Myeloma Foundation This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
#45
Dec 12, 2025 · 19 min
Episode 45 - Clinical Clips® Crucial Advances in Hemophilia
A number of clinical trials are underway to reduce and prevent bleeding episodes among patients with hemophilia and to improve their overall quality of life by improving joint health and addressing patient needs/concerns. These include both replacement and novel non-replacement therapies. This activity is designed to update healthcare professionals with the latest cutting-edge evidence in hemophilia treatment that was presented during the annual hematology meeting in Orlando, FL. The Clinical Clips format will equip clinicians with the knowledge and confidence to integrate new evidence into personalized approaches, optimize patient outcomes, and improve the overall quality of care in hemophilia A and B. Launch/Release Date: December 12, 2025 Activity Expiration Date: November 30, 2026 FACULTY Angela Weyand, MD Associate Professor, Pediatrics University of Michigan Medical School Pediatric Medical Director University of Michigan HTC Co-Director, Hematology and Pediatric and Adolescent Gynecology Program Ann Arbor, Michigan This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
#44
Dec 10, 2025 · 21 min
Episode 44 - Hematologic Cancer Updates | Key Advances in Leukemia, MDS and MF Podcast
Breakthroughs in hematologic cancers continue to emerge. Staying aligned with the newest insights from leading medical conferences is essential for healthcare providers committed to delivering cutting-edge care. Through impactful presentations, posters and abstracts, Dr. Raajit Rampal provides expert commentary on the latest advances in Leukemia, Myelodysplastic Syndromes (MDS) and Myelofibrosis (MF) presented at the annual hematology meeting in Orlando, FL. Launch/Release Date: December 10, 2025 Activity Expiration Date: November 30, 2026 FACULTY Raajit Rampal, MD, PhD Director, Myeloproliferative Neoplasms Program Director, Center for Hematologic Malignancies Memorial Sloan Kettering Cancer Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Jul 7, 2025 · 51 min
Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring Evidence, Guidelines and Best Practices
In this podcast, Dr. Cindy Neunert, provides expert insights into emerging data on ITP pathophysiology, diagnosis, and treatment, equipping healthcare providers with the knowledge to translate new research into clinical practice and improve pediatric patient care. Launch Date: July 7, 2025 Release Date: July 7, 2025 Expiration Date: June 30, 2026 FACULTY Cindy Neunert, MD Division of Pediatric Hematology Oncology, and Stem Cell Transplantation Columbia University Irving Medical Center New York, New York This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Feb 4, 2025 · 20 min
Episode 42 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 4: Patient Perspective in Hemophilia Care
There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.
Feb 4, 2025 · 6 min
Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms
There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.
Feb 4, 2025 · 20 min
Episode 40 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 2: Clinical Evidence on Novel Therapy Options in Hemophilia
There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.
Feb 4, 2025 · 21 min
Episode 39 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 1: Rationale and Potential of Gene Therapy and Rebalancing Agents in Hemophilia
There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.
Jan 20, 2025 · 47 min
Episode 38 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 5: Secondary HLH/MAS & Updates from ASH
Conversations in IFN-y explores the latest advancements in understanding and managing secondary hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), with updates from ASH 2024. Featuring discussions by leading experts, the educational activity covers breakthroughs in diagnostic technologies. Topics covered include AI-based histology models and PET/CT imaging, therapeutic innovations such as emapalumab and reduced-intensity conditioning for HSCT. The implications of these findings for improving outcomes in diverse patient populations, including malignancy- and pregnancy-associated HLH will also be discussed. Launch Date: January 9, 2025 Release Date: January 9, 2025 Expiration Date: December 31, 2025 FACULTY Pui Lee, MD Assistant Professor of Pediatrics Boston Childrens Hospital Ashish Kumar, MD, PhD Professor of Pediatrics Cincinnati Children's Hospital Medical Center Alexei Grom, MD Professor of Pediatrics Research Director Division of Rheumatology Cincinnati Children’s Hospital Medical Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Jan 20, 2025 · 18 min
Epsiode 37 - What’s New Doc? End of the Year Updates on CAR T-cell Therapy in Multiple Myeloma
What’s New Doc?: CAR T-cells in Multiple Myeloma, highlights key studies and publications from 2024 on the use of these agents in earlier lines of treatment. Dr. Mikhael details how approved and emerging CAR T cell agents in multiple myeloma will impact the treatment landscape and how to better integrate these agents to enable improved outcomes among patients. Launch Date: December 19, 2024 Release Date: December 19, 2024 Expiration Date: November 30, 2025 FACULTY Joseph Mikhael, MD, MEd, FRCPC, FACP Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center Chief Medical Officer, International Myeloma Foundation Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute Adjunct Professor, College of Health Solutions, Arizona State University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Jan 20, 2025 · 47 min
Episode 36 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 4: Updates from ACR Convergence 2024
In this Conversations in IFN-y podcast episode, emerging data from the 2024 ACR meeting is discussed, highlighting advancements in understanding genetic drivers, cytokine dynamics, and biomarkers like IL-18 and CXCL9 for improved diagnosis and monitoring. Expert insights explore new findings on liver and lung pathology in MAS, as well as updates on therapeutic innovations, including JAK inhibitors and emapalumab, and their roles in enhancing patient outcomes. Practical strategies are provided for integrating the latest research and cutting-edge diagnostics into clinical practice. Launch Date: December 19, 2024 Release Date: December 19, 2024 Expiration Date: November 30, 2025 FACULTY Pui Lee, MD Assistant Professor of Pediatrics Boston Children's Hospital Alexei Grom, MD Professor of Pediatrics Research Director Division of Rheumatology Cincinnati Children’s Hospital Medical Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Jan 20, 2025 · 26 min
Episode 35 - 2024 Highlights and Hindsight in CLL End of Year Updates
In Highlights and Hindsight in CLL, Dr. Matthew Davids will describe the most significant ongoing studies and publications in CLL from 2024 and will detail their impact on the treatment continuum. This activity will enable participants to stay updated on the most relevant breakthroughs and improve outcomes among patients. Launch Date: December 18, 2024 Release Date: December 18, 2024 Expiration Date: November 30, 2025 FACULTY Matthew Davids, MD, MMSc Director of Clinical Research, Division of Lymphoma Dana-Farber Cancer Institute This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Jan 20, 2025 · 16 min
Episode 34 - Clinical Clips in Acute Myeloid Leukemia: Key Updates and Breakthroughs from ASH 2024
This podcast Clinical Clip features a leading expert highlighting the latest advances in Acute Myeloid Leukemia(AML) treatments presented at the 66th ASH Annual Meeting and Exposition from December 7-10, 2024, in San Diego, CA. Launch Date: December 16, 2024 Release Date: December 16, 2024 Expiration Date: November 30, 2025 FACULTY Naval Daver, MD Director, Leukemia Research Alliance Program, Professor of Medicine Department of Leukemia MD Anderson Cancer Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link prior to listening to this podcast.
Jan 20, 2025 · 22 min
Episode 33 - Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024
Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024, will focus on the most exciting abstracts in hemophilia A and B that would be impactful for improved patient care. Dr. Guy Young will discuss the utility of key new evidence on replacement and non-replacement therapy to overcome current limitations and enable improved outcomes among patients. Launch Date: December 12, 2024 Release Date: December 12, 2024 Expiration Date: November 30, 2025 FACULTY Guy Young, MD Professor of Pediatrics University of Southern California Keck School of Medicine Director, Hemostasis and Thrombosis Center Children’s Hospital Los Angeles This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast. https://www.practicepointcme.com/CMEHome/clinical-clips-in-hemophilia-cutting-edge-advances-presented-at-ash-2024-1
Jan 20, 2025 · 25 min
Episode 32 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 3: Primary HLH
This third podcast episode in the series explores advanced understanding of primary hemophagocytic lymphohistiocytosis (HLH), focusing on its genetic basis, diagnostic innovations, and treatment strategies. The discussion highlights the pathophysiology of HLH as an interferon gamma (IFN-γ) driven disease, emphasizing the role of novel diagnostic tools such as flow cytometry and genetic panels. The panel also examines emerging therapies, including JAK inhibitors and IFN-γ monoclonal antibody (emapalumab), in improving outcomes for both primary and secondary HLH. Practical insights into balancing immunosuppression with efficacy offer guidance for optimizing patient care. Launch Date: December 2, 2024 Release Date: December 2, 2024 Expiration Date: November 30, 2025 FACULTY Scott Canna, MD Assistant Professor of Pediatrics Childrens Hospital of Philadelphia Pui Lee, MD Assistant Professor of Pediatrics Boston Childrens Hospital Ashish Kumar, MD, PhD Professor of Pediatrics Cincinnati Children’s Hospital Medical Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast. https://www.practicepointcme.com/CMEHome/conversations-in-ifn-y-driven-diseases-decoding-the-gamma-signal-1

Showing 1–20 of 20 episodes